Patents/Assignees

Shanghai Hengrui Pharmaceutical Co., Ltd.

23 patents in portfolio

US11780923utility2023
PD-L1 Antibody, Antigen-binding Fragment Thereof and Medical Application Thereof
0 cites
US11717559utility2023
Interleukin 15 Protein Complex and Use Thereof
0 cites
US11654194utility2023
PD-L1 Antibody Pharmaceutical Composition and Use Thereof
0 cites

← PreviousPage 2 of 2